NewVale Capital

Argonaut specializes in contract manufacturing for biopharmaceutical, diagnostics, and life science companies. Its services include high-yield aseptic fill/finish, reagent formulation, filling, kitting, lyophilization, and analytical support, catering to diverse outsourcing needs.

Aizon is an AI software provider that specializes in optimizing manufacturing operations within highly regulated industries such as biotech and pharmaceuticals. Based in San Francisco with an additional office in Barcelona, the company offers a Software-as-a-Service platform that integrates various data sources to provide actionable insights across all manufacturing sites. Aizon's platform supports batch process optimization, anomaly detection, root cause analysis, and asset performance management, among other features. The company was founded in 2013 and formerly operated under the name bigfinite Inc., changing its name to Aizon in October 2020.

Beaconcure is a technology company that specializes in automated solutions for clinical data validation, particularly in the context of drug development. The company offers statistical analysis validation software that addresses critical challenges in regulatory approvals. Its platform incorporates machine learning and proprietary algorithms to facilitate query development, discovery, and fulfillment, enabling the efficient extraction of data from evolving databases. By minimizing human error and expediting the regulatory approval process, Beaconcure's solutions provide significant value to clients, enhancing their decision-making capabilities during clinical trials and regulatory submissions.